Senior insider sale
Chief Operating Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$33.41M
397.21K shares
What this filing means
MONIA BRETT P plans to sell 397.21K shares of IONIS PHARMACEUTICALS INC valued at approximately $33.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/6/2026ACC: 0001972481-26-000045
Officer· Chief Operating Officer
Since Jul 2018
397.21K
Shares to sell
$33.41M
Approx. market value
290.20K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
1/15/2026
290.20KTotal acquired290.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Restricted Stock Units Equity Compensation | 290.20K | — |
| Total | 290.20K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
62.97K
Market value
$5.22M
1/30/2026
—Completed
Units to sell
44.03K
Market value
$3.36M
1/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
290.20K
Market value
$24.83M
2/6/2026
Total
Units
397.21K
Value
$33.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/30/2026 | 62.97K | $5.22M | — | Completed |
1/16/2026 | 44.03K | $3.36M | — | Completed |
| Planned — Approximate Date | ||||
2/6/2026 | 290.20K | $24.83M | Nasdaq | Planned |
| Total | 397.21K | $33.41M | ||